World's Best Scientists 2026 revealed!
Award Badge
Medicine
Canada
2023

D-Index & Metrics

Medicine

D-Index
140
Citations
114974
World Ranking
1654
National Ranking
55

Research.com Recognitions

  • 2023 - Research.com Medicine in Canada Leader Award

Overview

John W. Eikelboom is affiliated with the Population Health Research Institute in Canada and has a significant body of research within the field of Medicine, particularly in Cardiology and Cardiovascular Medicine.

Their research covers several subfields, including Internal Medicine, Surgery, Epidemiology, and Molecular Biology. Major topics addressed in their work include Atrial Fibrillation Management and Outcomes, Antiplatelet Therapy and Cardiovascular Diseases, Venous Thromboembolism Diagnosis and Management, Cardiac Arrhythmias and Treatments, Acute Ischemic Stroke Management, Inflammasome and Immune Disorders, and Acute Myocardial Infarction Research.

Frequent co-authors in their research collaborations include:

  • Salim Yusuf
  • Stuart J. Connolly
  • Jackie Bosch
  • Deepak L. Bhatt
  • Renato D. Lópes

John W. Eikelboom has published extensively in notable medical journals. Leading venues for their work are:

  • European Heart Journal
  • Journal of the American College of Cardiology
  • Circulation
  • Thrombosis and Haemostasis
  • Canadian Journal of Cardiology

Selected recent papers authored or co-authored by them include:

  • COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up (2020, Journal of the American College of Cardiology)
  • Colchicine in Patients with Chronic Coronary Disease (2020, New England Journal of Medicine)
  • 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants (2020, Journal of the American College of Cardiology)
  • Tranexamic Acid in Patients Undergoing Noncardiac Surgery (2022, New England Journal of Medicine)
  • Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention (2021, Circulation)

Best Publications

  • Dabigatran versus warfarin in patients with atrial fibrillation

    Stuart J. Connolly;Michael D. Ezekowitz;John Eikelboom;Jonas Oldgren

  • Standardized Bleeding Definitions for Cardiovascular Clinical Trials A Consensus Report From the Bleeding Academic Research Consortium

    Roxana Mehran;Sunil V. Rao;Deepak L. Bhatt;C. Michael Gibson

  • COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up

    Behnood Bikdeli;Mahesh V. Madhavan;David Jimenez;Taylor Chuich

  • Apixaban in Patients with Atrial Fibrillation

    Stuart J. Connolly;John Eikelboom;Campbell Joyner;Hans-Christoph Diener

  • Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

    John W. Eikelboom;Stuart J. Connolly;Jackie Bosch;Gilles R. Dagenais

  • Idarucizumab for Dabigatran Reversal

    Charles V. Pollack;Paul A. Reilly;John Eikelboom;Stephan Glund

  • Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes

    John W. Eikelboom;Shamir R. Mehta;Sonia S. Anand;Changchun Xie

  • Dabigatran versus Warfarin in Patients with Mechanical Heart Valves

    John W. Eikelboom;Stuart J. Connolly;Martina Brueckmann;Christopher B. Granger

  • Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events

    John W. Eikelboom;Jack Hirsh;Jeffrey I. Weitz;Marilyn Johnston

  • Homocysteine and vascular disease.

    G J Hankey;J W Eikelboom

  • Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial

    John W. Eikelboom;Lars Wallentin;Stuart J. Connolly;Mike Ezekowitz

  • Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: An analysis of the RE-LY trial

    Lars Wallentin;Salim Yusuf;Michael D Ezekowitz;Marco Alings

  • Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence.

    John W. Eikelboom;Eva Lonn;Jacques Genest;Graeme Hankey

  • Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention : A Consensus Document From the Academic Research Consortium for High Bleeding Risk

    Philip Urban;Roxana Mehran;Roisin Colleran;Dominick J. Angiolillo

  • Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis

    S. G. Chu;R. C. Becker;P. B. Berger;D. L. Bhatt

  • Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range

    Stuart J. Connolly;Janice Pogue;John Eikelboom;Gregory Flaker

  • Idarucizumab for Dabigatran Reversal — Full Cohort Analysis

    Charles V. Pollack;Paul A. Reilly;Joanne van Ryn;John W. Eikelboom

  • The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy).

    Paul A. Reilly;Thorsten Lehr;Sebastian Haertter;Stuart J. Connolly

  • Dose comparisons of clopidogrel and aspirin in acute coronary syndromes.

    R. Mehta;Jean-Pierre Bassand;Rafael Diaz;Estudios Clinicos Latinoamérica

  • Low-dose colchicine for secondary prevention of cardiovascular disease

    Stefan M. Nidorf;John W. Eikelboom;Charley A. Budgeon;Peter L. Thompson

Frequent Co-Authors

Salim Yusuf
Salim Yusuf McMaster University
Stuart J. Connolly
Stuart J. Connolly McMaster University
Graeme J. Hankey
Graeme J. Hankey University of Western Australia
Jack Hirsh
Jack Hirsh McMaster University
Lars Wallentin
Lars Wallentin Uppsala University
Jeffrey I. Weitz
Jeffrey I. Weitz McMaster University
Robert G. Hart
Robert G. Hart Population Health Research Institute
Keith A.A. Fox
Keith A.A. Fox University of Edinburgh
Michael D. Ezekowitz
Michael D. Ezekowitz Lankenau Institute for Medical Research
Deepak L. Bhatt
Deepak L. Bhatt Mount Sinai Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to a wide range of online degrees and career advancements beyond traditional medical school. For those interested in direct patient care with a quicker route to employment, consider lpn programs that can lead to becoming a Licensed Practical Nurse in as little as 12-18 months.

Mental health is a growing field, and licensed nurses may pursue the online pmhnp programs to specialize further as Psychiatric Mental Health Nurse Practitioners, which offer flexibility and strong employment prospects.

If you are drawn to the administrative side of healthcare, the affordable healthcare administration degree online can be an excellent choice, preparing you for vital roles like healthcare manager or policy analyst. For those seeking advanced leadership roles, the cheapest mha programs online offer a cost-effective route to high-level positions in hospitals and other healthcare organizations.

These online programs provide flexible learning options while opening various career pathways in healthcare, allowing you to tailor your education to your professional goals and budget.

Best Scientists Citing John W. Eikelboom

Trending Scientists

Recently Published Articles